Last €11.50 EUR
Change Today +0.337 / 3.02%
Volume 10.7K
As of 3:05 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

nexus ag (NXU) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/17/14 - €14.45
52 Week Low
10/30/13 - €9.60
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NEXUS AG (NXU)

Related News

No related news articles were found.

nexus ag (NXU) Related Businessweek News

No Related Businessweek News Found

nexus ag (NXU) Details

NEXUS AG develops and sells software and hardware solutions for hospitals, psychiatric institutions, and rehabilitation and social institutions in Europe and the Middle East. It offers various information systems, such as NEXUS/HIS, for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/HOME for senior citizen and nursing homes; NEXUS/PAT.INT an administration information system for Swiss hospitals; and NEXUS/DIS, an interdisciplinary diagnostic information system. The company also provides NEXUS/GYNECOLOGY for obstoetric institutes and gynecology; NEXUS/PATHOLOGY for pathology and cytology institutions; NEXUS/RADIOLOGY, a radiology information and diagnosing system for radiology wards and offices; Clinic WinData, a medical diagnosing and equipment integration; and ASS.TEC, a process and SAP consulting system. In addition, it offers NEXUS/INFORMATION STORE, a management information system for hospitals; NEXUS/QM and NEXUS/CURATOR for quality management in the healthcare system; NEXUS/SPM for medical product sterilization processes in hospitals; NEXUS/CCC, a service and hotline system for customers; and NEXUS/IT, an outsourcing/services and SAP partner in the healthcare system. Further, the company provides NEXUS/MOBILE, an app for use on the mobile terminals of doctors and nurses; NEXUS/MEDICATION for prescribing, checking, providing, and monitoring medicines; NEXUS/PDMS for intensive care ward; NEXUS/OBSTETRICS, a gynecological and obstetrics software; NEXUS/REHA a solution from admission to discharge for rehabilitation institutions; NEXUS/CYTOLOGY for cytology institutions; and Asebis, a home care solution for the Swiss market. NEXUS AG is based in Villingen-Schwenningen, Germany.

650 Employees
Last Reported Date: 08/18/14

nexus ag (NXU) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nexus ag (NXU) Key Developments

Nexus AG Reports Earnings Results for the Second Quarter and First Half Ended June 30, 2014

Nexus AG reported earnings results for the second quarter and first half ended June 30, 2014. For the quarter, the company reported revenue of EUR 19,228,000 compared to EUR 17,768,000 a year ago. Operating profit was EUR 1,769,000 compared to EUR 1,623,000 a year ago. Profit before tax was EUR 1,785,000 compared to EUR 1,637,000 a year ago. Consolidated surplus was EUR 1,817,000 or EUR 0.13 per simple and diluted per share compared to EUR 1,619,000 or EUR 0.11 per simple and diluted per share a year ago. For the first half, the company reported revenue of EUR 37,823,000 compared to EUR 34,372,000 a year ago. Operating profit was EUR 3,581,000 compared to EUR 3,250,000 a year ago. Profit before tax was EUR 3,662,000 compared to EUR 3,298,000 a year ago. Consolidated surplus was EUR 3,622,000 or EUR 0.25 per simple and diluted per share compared to EUR 3,321,000 or EUR 0.23 per simple and diluted per share a year ago. Cash flow from current business transactions was EUR 5,064,000 compared to EUR 3,583,000 a year ago. Payment for investments in intangible and fixed assets was EUR 3,199,000 compared to EUR 2,060,000 a year ago.

Nexus AG Reports Earnings Results for the First Quarter of 2014

NEXUS AG reported earnings results for the first quarter of 2014. For the quarter, the company’s sales increased from EUR 16,604,000 first quarter 2013 to EUR 18,596,000 in the first quarter 2014. The result before taxes improved from EUR 1,662,000 to EUR 1,878,000. EBITDA increased by approx. 6.8% to EUR 3,460,000 from EUR 3,240,000 a year ago period. The cash flow in the first quarter developed especially strongly. The cash flow from current business transactions reached EUR 8,164,000 and consequently considerably surpassed the high value of the previous year of EUR 4,547,000.

Nexus AG Announces Consolidated Earnings Results for the Year 2013

Nexus AG announced consolidated earnings results for the year 2013. The company reported that it increased its consolidated sales of EUR 62,340,000 in the previous year to EUR 73,263,000 in 2013. The company was again able to achieve two-figure growth both in sales and revenue in 2013 and consequently continue its development of the previous years. The company’s result before tax on income improved from EUR 5,789,000 in 2012 to KEUR 7,078,000. The EBITDA reached EUR 13,998,000 following EUR 11,820,000 in the previous year. The result per share increased by 19.1% to 50 cents against 42 cents a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NXU:GR €11.50 EUR +0.337

NXU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
General Electric Co $25.45 USD +0.42
McKesson Corp $196.93 USD +3.84
Siemens AG €86.04 EUR +2.65
View Industry Companies

Industry Analysis


Industry Average

Valuation NXU Industry Range
Price/Earnings 20.0x
Price/Sales 1.9x
Price/Book 2.1x
Price/Cash Flow 10.5x
TEV/Sales 1.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEXUS AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at